Established in 2018, Arpeggio’s proprietary platform – developed by co-founders and Chief Executive Officer Joey Azofeifa, Chief Technology Officer Tim Read, and Chief Operating Officer Laura Norris – has built the largest database of nascent-RNA sequences in the world. Arpeggio's technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development. To learn more, visit https://www.arpeggiobio.com/